Article: | MedLuna.com

Overview

Journal Can Oncol Nurs J

Date 2024 Jun 26

PMID 38919461

Authors

Anne Choquette

Araby Sivananthan

Annie Guillemette

Erin OShaubhnessy

Martha Pinheiro-Maltez

Linda MacKeigan

Anne-Marie Langevin

L Lee Dupuis

Affiliations

Soon will be listed here.

References

Dupuis L, Taddio A, Kerr E, Kelly A, MacKeigan L . Development and validation of the pediatric nausea assessment tool for use in children receiving antineoplastic agents. Pharmacotherapy. 2006; 26(9):1221-31. DOI: 10.1592/phco.26.9.1221. View

Hinds P, Gattuso J, Billups C, West N, Wu J, Rivera C . Aggressive treatment of non-metastatic osteosarcoma improves health-related quality of life in children and adolescents. Eur J Cancer. 2009; 45(11):2007-14. PMC: 2820559. DOI: 10.1016/j.ejca.2009.04.020. View

Dupuis L, Lu X, Mitchell H, Sung L, Devidas M, Mattano Jr L . Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group. Cancer. 2016; 122(7):1116-25. PMC: 5138861. DOI: 10.1002/cncr.29876. View

Flank J, Sparavalo J, Vol H, Hagen L, Stuhler R, Chong D . The burden of chemotherapy-induced nausea and vomiting in children receiving hematopoietic stem cell transplantation conditioning: a prospective study. Bone Marrow Transplant. 2017; 52(9):1294-1299. DOI: 10.1038/bmt.2017.112. View

McKinnon K, Jupp J . Integration of a nausea and vomiting assessment tool into antineoplastic management of pediatric oncology patients. J Oncol Pharm Pract. 2019; 26(6):1353-1360. DOI: 10.1177/1078155219892666. View

Hesketh P, Bohlke K, Lyman G, Basch E, Chesney M, Clark-Snow R . Antiemetics: American Society of Clinical Oncology Focused Guideline Update. J Clin Oncol. 2015; 34(4):381-6. DOI: 10.1200/JCO.2015.64.3635. View

Patel P, Robinson P, Thackray J, Flank J, Holdsworth M, Gibson P . Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update. Pediatr Blood Cancer. 2017; 64(10). DOI: 10.1002/pbc.26542. View

Sommariva S, Pongiglione B, Tarricone R . Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: A systematic review. Crit Rev Oncol Hematol. 2015; 99:13-36. DOI: 10.1016/j.critrevonc.2015.12.001. View

Russo S, Cinausero M, Gerratana L, Bozza C, Iacono D, Driol P . Factors affecting patient's perception of anticancer treatments side-effects: an observational study. Expert Opin Drug Saf. 2013; 13(2):139-50. DOI: 10.1517/14740338.2013.830710. View

10.

Flank J, Nadeem K, Moledina S, Khanna M, Schindera C, Punnett A . Nausea and vomiting in children and adolescents receiving intrathecal methotrexate: A prospective, observational study. Pediatr Blood Cancer. 2017; 64(10). DOI: 10.1002/pbc.26603. View

11.

Farrell C, Brearley S, Pilling M, Molassiotis A . The impact of chemotherapy-related nausea on patients' nutritional status, psychological distress and quality of life. Support Care Cancer. 2012; 21(1):59-66. DOI: 10.1007/s00520-012-1493-9. View

12.

Vol H, Flank J, Lavoratore S, Nathan P, Taylor T, Zelunka E . Poor chemotherapy-induced nausea and vomiting control in children receiving intermediate or high dose methotrexate. Support Care Cancer. 2015; 24(3):1365-71. DOI: 10.1007/s00520-015-2924-1. View

13.

Gilmore J, Peacock N, Gu A, Szabo S, Rammage M, Sharpe J . Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE Study. J Oncol Pract. 2013; 10(1):68-74. DOI: 10.1200/JOP.2012.000816. View

14.

Dupuis L, Boodhan S, Sung L, Portwine C, Hain R, McCarthy P . Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients. Pediatr Blood Cancer. 2011; 57(2):191-8. PMC: 6554029. DOI: 10.1002/pbc.23114. View

15.

Dupuis L, Milne-Wren C, Cassidy M, Barrera M, Portwine C, Johnston D . Symptom assessment in children receiving cancer therapy: the parents' perspective. Support Care Cancer. 2009; 18(3):281-99. DOI: 10.1007/s00520-009-0651-1. View

16.

Evans A, Malvar J, Garretson C, Pedroja Kolovos E, Baron Nelson M . The Use of Aromatherapy to Reduce Chemotherapy-Induced Nausea in Children With Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial. J Pediatr Oncol Nurs. 2018; 35(6):392-398. DOI: 10.1177/1043454218782133. View

17.

Dupuis L, Kelly K, Krischer J, Langevin A, Tamura R, Xu P . Acupressure bands do not improve chemotherapy-induced nausea control in pediatric patients receiving highly emetogenic chemotherapy: A single-blinded, randomized controlled trial. Cancer. 2017; 124(6):1188-1196. PMC: 5839969. DOI: 10.1002/cncr.31198. View

18.

Clinton F, Dowling M, Capra M . An audit of chemotherapy-induced nausea and vomiting in children. Nurs Child Young People. 2012; 24(7):18-23. DOI: 10.7748/ncyp2012.09.24.7.18.c9274. View

19.

Patel P, Lavoratore S, Flank J, Kemp M, Vennettilli A, Vol H . Chemotherapy-induced nausea and vomiting control in pediatric patients receiving ifosfamide plus etoposide: a prospective, observational study. Support Care Cancer. 2019; 28(2):933-938. DOI: 10.1007/s00520-019-04903-0. View

20.

Hesketh P, Gralla R, Bois A, Tonato M . Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity. Support Care Cancer. 1998; 6(3):221-7. DOI: 10.1007/s005200050157. View